Growth Hormone Axis
Performance
Preclinical
Research chemical

MGF (Mechano Growth Factor)

Also known as MGF · IGF-1 Ec · mechano growth factor

New

Reconstitution & dosing guide

2 mg vial — research phases, recon steps, and a live unit calculator.

Open guide

Available sizes & price

Catalog only

2mg x 10 vials

MGF · Not in current stock

$25 / vial

Add

Prices per vial · Research use only · Not medical advice.

Splice variant of IGF-1 expressed in response to mechanical overload; researched for localized muscle repair. Short half-life; PEGylated MGF is the stabilized catalog cousin.

How to picture it

After hard mechanical stress, muscle tissue issues a local repair broadcast linked to IGF-Ec signaling and satellite-cell activity. Native MGF is short-lived — a neighborhood text, not a system-wide announcement. Picture localized muscle-repair signaling right where loading happened, before PEGylation extends the message.

Research focus & benefits

  • Local muscle repair and IGF-Ec research
  • Satellite-cell and mechanical-load studies
  • Short-acting MGF pathway interest

Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.

Overview

Mechano Growth Factor is the IGF-1Ec splice variant upregulated in muscle after stretch/damage. It is studied for autocrine repair and satellite-cell activation. Native MGF is rapidly degraded; PEG-MGF extends activity. Catalog often lists both 2 mg vials.

Mechanism

Localized IGF-1 receptor and distinct C-terminal domain signaling associated with muscle repair and hyperplasia-related pathways in preclinical literature.

Research uses

  • Muscle damage and overload models
  • Satellite cell activation research
  • Comparison with IGF-1 LR3 and PEG-MGF

Research dosing notes

Research discussions often use local mcg injections post-training. PEG-MGF used when longer action desired. No clinical standard.

Open full reconstitution & dosing guide →

Half-life / kinetics

Very short (minutes) for native MGF

Common research routes

Subcutaneous injection
Intramuscular injection

Reported considerations

  • Hypoglycemia risk (IGF axis)
  • Injection trauma
  • Unknown long-term safety

Contraindications / cautions

  • Active cancer
  • Diabetic hypoglycemia risk
  • Pregnancy

Common research stacks

  • PEG-MGF
  • IGF-1 LR3
  • CJC/Ipamorelin

Legal / access note

Research growth factor. Not approved for muscle building.